Universidad Peruana Cayetano Heredia

Survival in patients with carcinomas presenting with bone metastasis at diagnosis: a SEER population-based cohort study

Mostrar el registro sencillo del ítem

dc.contributor.author Younis, Manaf H.
dc.contributor.author Fuentes Rivera, Lorena
dc.contributor.author Summers, Spencer
dc.contributor.author Pretell Mazzini, Juan
dc.date.accessioned 2021-04-13T20:50:59Z
dc.date.available 2021-04-13T20:50:59Z
dc.date.issued 2020
dc.identifier.uri https://hdl.handle.net/20.500.12866/9140
dc.description.abstract INTRODUCTION: Carcinoma metastasis to bone is a common reason for consultation to orthopedic surgeons. The presence of bone metastases (BM) is usually associated with poor prognosis which is worsened in the presence of synchronous metastases. The purpose of this study was to: (1) identify the most common carcinomas presenting with BM at diagnosis, to (2) analyze their survival, and (3) compare this against the survival of patients with additional synchronous metastasis based on a large population analysis. MATERIALS AND METHODS: Patients diagnosed with carcinoma between January 2010 and December 2015 were identified from the Surveillance, Epidemiology and End Results (SEER) database. The most common carcinomas presenting with BM at diagnosis were identified. Survival based on the presence of BM and synchronous metastases (lung, brain, liver, lymph nodes) was evaluated with Kaplan-Meier analysis. Five-year survival (%) stratified by carcinoma type was calculated. Hazard ratio (HR) for mortality comparing isolated BM to other synchronous metastases was performed. RESULTS: A total of 4.85% of patients (98,606/2,035,204) with carcinoma presented with BM at diagnosis, most commonly from a lung primary. Five-year survival with isolated BM was lowest in patients with pancreatic carcinoma (5.8%, 95% CI 3.0-9.9%), and highest in patients with breast carcinoma (41.1%, 95% CI 38.6-43.5%). Synchronous metastases increased significantly the risk of mortality within the majority of carcinomas. CONCLUSION: BM at diagnosis has a poor prognosis which is worsened if synchronous metastases are present; a fact to consider when planning orthopedic interventions. LEVEL OF EVIDENCE: Level III, prognostic study. en_US
dc.language.iso eng
dc.publisher Springer
dc.relation.ispartofseries Archives of Orthopaedic and Trauma Surgery
dc.rights info:eu-repo/semantics/restrictedAccess
dc.rights.uri https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.subject Bone metastasis en_US
dc.subject Breast en_US
dc.subject Carcinoma en_US
dc.subject Lung en_US
dc.subject Pancreas en_US
dc.subject Prostate en_US
dc.subject Renal en_US
dc.subject Survival en_US
dc.title Survival in patients with carcinomas presenting with bone metastasis at diagnosis: a SEER population-based cohort study en_US
dc.type info:eu-repo/semantics/article
dc.identifier.doi https://doi.org/10.1007/s00402-020-03417-3
dc.subject.ocde https://purl.org/pe-repo/ocde/ford#3.02.11
dc.subject.ocde https://purl.org/pe-repo/ocde/ford#3.03.11
dc.relation.issn 1434-3916


Ficheros en el ítem

Ficheros Tamaño Formato Ver

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

info:eu-repo/semantics/restrictedAccess Excepto si se señala otra cosa, la licencia del ítem se describe como info:eu-repo/semantics/restrictedAccess

Buscar en el Repositorio


Listar

Panel de Control

Estadísticas